If you, your children, or your grandchildren have asthma, you know how important an inhaler can be.
On April 4, 2017, GlaxoSmithKline (GSK) announced that they were voluntarily recalling almost 600,000 Ventolin inhalers.
According to the Asthma and Allergy Foundation of America, GSK is recalling the inhalers due to faulty packaging.
The company received some complaints that the inhalers were leaking while in the pouches, which means the inhalers could provide fewer doses than shown on the dose counter.
According to the FDA, the voluntary Class II recall means that “use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
What this means in plain English is that there are no serious adverse health effects — the only thing people need to be concerned about is running out of doses sooner than expected.
[H/T: Good Housekeeping]
GlaxoSmithKline (GSK) issued a voluntary recall on Ventolin HFA 200D inhalers on April 4, 2017.
Find out more about the specifics on the recall below.
This recall is not a consumer recall, so if you have one, you are not being asked to return it.
Instead, the recall is a precautionary measure for wholesalers, retailers, hospitals, and pharmacies.
The lot numbers that are affected are 6ZP0003, 6ZP9944, and 6ZP9848.
To find the lot number, look at the metal part of the inhaler.
Although patients are not being asked to return their inhalers, you can call GSK’s response center at 1-888-825-5249 if you have any questions.
Additionally, if you are planning on filling a Ventolin HFA 200D prescription, the recall should not affect your pharmacy or supplier.
However, if your inhaler is not relieving symptoms, you should seek medical treatment right away.
If you think everyone with asthma should know about this recall, please SHARE this article on Facebook!